244 results on '"Kalayci, Arzu"'
Search Results
2. Patient Adherence to Secondary Prevention Therapies After an Acute Coronary Syndrome: A Scoping Review
3. ApoA-I Infusion Therapies Following Acute Coronary Syndrome: Past, Present, and Future
4. Abstract 14367: Residual Cardiovascular Risk Despite Secondary Prevention: Data From Contemporary Cardiovascular Outcomes Trials Spanning 2010 - 2021
5. Relation of White Blood Cell Count to Bleeding and Ischemic Events in Patients With Acute Coronary Syndrome (from the ATLAS ACS 2-TIMI 51 Trial)
6. Dual antithrombotic plus adjunctive antiinflammatory therapy to improve cardiovascular outcome in atrial fibrillation patients with concurrent acute coronary syndrome: A triple-pathway strategy
7. Extended-duration betrixaban versus shorter-duration enoxaparin for venous thromboembolism prophylaxis in critically ill medical patients: an APEX trial substudy
8. Total bleeding with rivaroxaban versus warfarin in patients with atrial fibrillation receiving antiplatelet therapy after percutaneous coronary intervention
9. Most Promising Therapies in Interventional Cardiology
10. Biological basis and proposed mechanism of action of CSL112 (Apolipoprotein A-I [Human]) for prevention of major adverse cardiovascular events in patients with myocardial infarction
11. Left atrial electromechanical conduction time predicts atrial fibrillation in patients with mitral stenosis: a 5-year follow-up speckle-tracking echocardiography study
12. A rare cause of retinal artery embolism: Accessory mitral valve tissue
13. Association of Anemia with Venous Thromboembolism in Acutely Ill Hospitalized Patients: An APEX Trial Substudy
14. Inverse relationship between body mass index and risk of venous thromboembolism among medically ill hospitalized patients: Observations from the APEX trial
15. Predictors of coronary artery aneurysm after stent implantation in patients with ST-segment elevation myocardial infarction treated with primary percutaneous coronary intervention
16. Early and late recurrent cardiovascular events among high‐risk patients with an acute coronary syndrome: Meta‐analysis of phase III studies and implications on trial design
17. Early and Late Recurrent Cardiovascular Risk in Patients With Recent Acute Coronary Syndrome: Meta-Analysis and Implications in Trial Design†
18. Cholesterol Efflux Capacity and Its Association With Adverse Cardiovascular Events: A Systematic Review and Meta-Analysis
19. Cholesterol Efflux Capacity and Measurement Assays: A Novel Biomarker of High-Density Lipoprotein (HDL) Function
20. Biological Basis and Proposed Mechanism of Action of CSL112 (Apolipoprotein A-I [Human]) for Prevention of Major Adverse Cardiovascular Events in Patients post Myocardial Infarction
21. Assessment of atrial conduction time in patients with polycystic ovary syndrome
22. Discrepancies between Doppler and catheter gradients in ventricular septal defect: a correction of localized gradients from pressure recovery phenomenon
23. Mean platelet volume in patients with non-alcoholic fatty liver disease: is mean platelet volume ready as a surrogate marker?
24. EARLY AND LATE RECURRENT CARDIOVASCULAR RISK IN PATIENTS WITH RECENT ACUTE CORONARY SYNDROME - META-ANALYSIS AND IMPLICATIONS IN TRIAL DESIGN
25. ASSOCIATION OF CHOLESTEROL EFFLUX CAPACITY WITH ADVERSE CARDIOVASCULAR OUTCOMES - A META-ANALYSIS
26. † Evaluating the Residual Risk of Recurrent Cardiovascular Events in Contemporary Cardiovascular Outcomes Trials
27. Drospirenone-Containing Oral Contraceptives and Risk of Adverse Outcomes After Myocardial Infarction
28. Left Atrial Deformation Parameters Predict Left Atrial Appendage Function and Thrombus in Patients in Sinus Rhythm with Suspected Cardioembolic Stroke: A Speckle Tracking and Transesophageal Echocardiography Study
29. An Incomplete Heart with Incomplete Lungs
30. Double Cardiac Silhouette on Lateral Chest X-Ray Graphy
31. The importance of the conus artery in patients with obstructive coronary artery disease
32. Mitral Regurgitation due to Papillary Muscle Dyssynchrony during Trastuzumab Treatment
33. Echocardiographic assessment of insulin‐like growth factor binding protein‐7 and early identification of acute heart failure
34. Mitral Regurgitation due to Papillary Muscle Dyssynchrony during Trastuzumab Treatment
35. Reduction of Cardiovascular Mortality and Ischemic Events in Acute Medically Ill Patients
36. Üçüncü Basamak Bir Merkezden Kardiyak Arrest Serisi
37. Prognostic Value of Red Cell Distribution Width in Acute Coronary Syndrome
38. Acute carotid stent thrombosis
39. Eosinophilic inflammation in spontaneous coronary artery dissection: A potential therapeutic target?
40. Subclinical Left Ventricular Dysfunction in Chronic Asymptomatic Alcoholic Patients
41. Successful Recanalization of Acute Superior Mesenteric Artery Thrombotic Occlusion
42. Asymptomatic Deep Vein Thrombosis is Associated with an Increased Risk of Death: Insights from the APEX Trial
43. Betrixaban for first-line venous thromboembolism prevention in acute medically ill patients with risk factors for venous thromboembolism
44. Safety and efficacy of non–vitamin K oral anticoagulant for atrial fibrillation patients after percutaneous coronary intervention: A bivariate analysis of the PIONEER AF-PCI and RE-DUAL PCI trial
45. A Pushed Descending Aorta due to Hiatal Hernia
46. Echocardiographic assessment of right ventricle free wall strain for prediction of right coronary artery proximal lesion in patients with inferior myocardial infarction
47. Complete aortic prosthetic valve dehiscence after modified Bentall-De Bono procedure
48. Review of myocardial perfusion imaging in the state of unstable angina
49. Re: Left Ventricular Strain and Rotation by 2-D Speckle Tracking Echocardiography Identify Early Alcoholic Cardiomyopathy
50. TCT-700 Comparison of the Predictive Performance of Dilemma and P20DAC2 Scoring Systems to Determine the Significance of LAD Intermediate Lesions
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.